Judge Denies Injunction Against Potential Tyvaso Competitor, Cites Premature Action
A D.C. federal judge on Friday worked against drug manufacturer United Therapeutics Corp.’s effort to stop the U.S. Food and Drug Administration’s (FDA) potential approval of a new competitor for its highly successful pulmonary hypertension treatment, Tyvaso. The judge determined that United Therapeutics was essentially trying to contest an agency action prior to that action…